Mandate

Vinge has advised Autoliv in connection with financing from AB Svensk Exportkredit (publ) (”SEK”) and guarantees from Exportkreditnämnden (”EKN”) 

June 03, 2020

Vinge has advised worldwide leader in vehicle safety systems, Autoliv, Inc., and its subsidiaries in connection with the entering into of a new SEK 6,000,000,000 loan facility, divided in SEK 3,000,000,000 as a 2-year trance and SEK 3,000,000,000 as a 5-year trance, with SEK, supported by guarantees from EKN.

In connection with the new loan facility becoming available, Autoliv’s existing financing of SEK 1,200,000,000 with SEK will be repaid.
 
Vinge’s team consisted of partner Albert Wållgren and associates Josefine Lanker and Jolinn Uhlin.
 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025